Method for the purification of antibodies

Patent metadata

Field	Value
Publication number	US-11034754-B2
Application number	US-201715458368-A
Country	US
Kind code	B2
Filing date	Mar 14, 2017
Priority date	May 25, 2005
Publication date	Jun 15, 2021
Grant date	Jun 15, 2021

Abstract

A method for the purification of immunoglobulins by ion exchange chromatography is described. The chromatographic method uses a weak ion exchange resin and a single step elution process for the purification of an immunoglobulin. Additionally a method for the determination of the salt concentration for the single step elution of an immunoglobulin from an ion exchange resin is described.

First claim

The invention claimed is:

1. A method for purifying a monomeric monoclonal anti-HER2 antibody from aggregates thereof, wherein the method comprises:
a) purifying a monoclonal anti-HER2 antibody by protein A affinity chromatography;
b) providing a solution comprising the monoclonal anti-HER2 antibody of step a);
c) bringing the solution of step b) and a weak cation exchange material in contact under conditions whereby the monoclonal anti-HER2 antibody binds to the weak cation exchange material; and
d) recovering the monomeric monoclonal anti-HER2 antibody from the weak cation exchange material in a single step by using a second solution comprising a buffer substance and a salt wherein the conductivity of the second solution is increased by changing one condition all at once from a starting value to a final value so as to obtain the monomeric monoclonal anti-HER2 antibody purified from aggregates thereof,
wherein the buffer substance and salt are the same and the monoclonal anti-HER2 antibody has an isoelectric point (p1) of 6.0 or higher.

2. The method according to claim 1 , wherein the buffer substance of step d) is selected from the group consisting of citric acid, a salt of citric acid, phosphoric acid, and a salt of phosphoric acid.

3. The method according to claim 1 , wherein the method is a chromatographic or a batch method.

4. The method according to claim 1 , wherein the salt of step d) is selected from the group consisting of sodium chloride, sodium sulphate, potassium chloride, potassium sulfate, salts of citric acid, salts of phosphoric acid, and mixtures thereof.

5. The method according to claim 2 , wherein the method is a chromatographic or a batch method.

6. The method according to claim 1 , wherein the pH is kept constant in the single step.

7. The method according to claim 2 , wherein the pH is kept constant in the single step.

8. The method according to claim 3 , wherein the pH is kept constant in the single step.

9. The method according to claim 1 , wherein the salt in elution step d) is added at the same time as the buffer substance.

10. The method according to claim 1 , wherein the weak cation exchange material is a carboxy-methyl weak cation exchange material.

11. The method according to claim 1 , wherein the monoclonal anti-HER2 antibody is a member of the immunoglobulin class G.

12. The method according to claim 1 , wherein the second solution in the recovery step d) has a pH value of from pH 3.0 to pH 7.0.

13. The method according to claim 2 , wherein the weak cation exchange material is a carboxy-methyl weak cation exchange material.

Assignees

• Hoffmann La Roche

Inventors

• Falkenstein Roberto
• Kolb Burkard
• Sebald Maria

Classifications

• C07K1/14 Primary

  Extraction; Separation; Purification · CPC title

• C07K1/18

  Ion-exchange chromatography · CPC title

• C07K16/00 Primary

  Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies · CPC title

• B01D15/362 Primary

  Cation-exchange · CPC title

• B01D15/363

  Anion-exchange · CPC title